Cystatin m: a novel candidate tumor suppressor gene for breast cancer.
about
Methylation-dependent silencing of CST6 in primary human breast tumors and metastatic lesionsCharacterization of DNA Methylation in Circulating Tumor CellsNovel tumor antigens elicit anti-tumor humoral immune reactions in a subset of patients with polycythemia veraGene expression profiling of papillary thyroid carcinoma identifies transcripts correlated with BRAF mutational status and lymph node metastasis.Cystatin E/M suppresses legumain activity and invasion of human melanomaSeed in soil, with an epigenetic viewInactivation of the cystatin E/M tumor suppressor gene in cervical cancerDNA methylation-dependent silencing of CST6 in human breast cancer cell lines.Frequent epigenetic inactivation of cystatin M in breast carcinoma.Cystatin M loss is associated with the losses of estrogen receptor, progesterone receptor, and HER4 in invasive breast cancerMicroarray and proteomic analysis of breast cancer cell and osteoblast co-cultures: role of osteoblast matrix metalloproteinase (MMP)-13 in bone metastasis.Identification of cystatin SA as a novel inhibitor of acid ceramidase.Transcriptional changes associated with breast cancer occur as normal human mammary epithelial cells overcome senescence barriers and become immortalized.Structural Dynamics Investigation of Human Family 1 & 2 Cystatin-Cathepsin L1 Interaction: A Comparison of Binding ModesIn Silico Analysis Validates Proteomic Findings of Formalin-fixed Paraffin Embedded Cutaneous Squamous Cell Carcinoma Tissue.Differential secretome analysis reveals CST6 as a suppressor of breast cancer bone metastasisInvasion suppressor cystatin E/M (CST6): high-level cell type-specific expression in normal brain and epigenetic silencing in gliomas.Cystatin E/M Suppresses Tumor Cell Growth through Cytoplasmic Retention of NF-κB.Cystatin D is a candidate tumor suppressor gene induced by vitamin D in human colon cancer cells.Frequent loss of cystatin E/M expression implicated in the progression of prostate cancer.Cystatin superfamily.Cystatins in immune system.p53 directly activates cystatin D/CST5 to mediate mesenchymal-epithelial transition: a possible link to tumor suppression by vitamin D3Differential cathepsin responses to inhibitor-induced feedback: E-64 and cystatin C elevate active cathepsin S and suppress active cathepsin L in breast cancer cellsDNA hypermethyation and silencing of PITX1 correlated with advanced stage and poor postoperative prognosis of esophageal squamous cell carcinoma.Low-level internalization of cystatin E/M affects legumain activity and migration of melanoma cells.Modelling family 2 cystatins and their interaction with papain.Gene expression in the mammary gland tissue of female Fischer 344 and Lewis rats after magnetic field exposure (50 Hz, 100 μT) for 2 weeks.Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer.
P2860
Q24648542-020E7C9E-0989-4103-84D2-6D4F4367783CQ26778427-4ED93480-F129-4DCB-9684-7EA03C0D5471Q33264010-E277637B-93C7-4245-BCF8-C6C2F96332EDQ33357290-7E8DAB0D-9473-47B4-A364-157F565C121CQ33523914-094F771C-2DAD-470C-8B3D-E0DF8BAE57BAQ33754753-7D42E5BD-01D7-47CF-BC23-3E8CFFAA5013Q34282467-168DF535-0707-4C4E-A8CD-FC9CDA8BE39CQ34574105-599B8BD2-805C-4E21-AF5D-27E851E022AEQ34581120-C8A33846-5905-4F96-BCDD-6006E996BAF5Q34613588-848D103B-A2EA-442E-981B-BD79661B0E14Q35310572-243F5571-BB78-4908-9381-68B19AD58BCDQ35371286-F274C16A-66D2-44A4-8371-07DCED09218EQ35614098-468C6452-4567-45FA-9A6C-1F18478C8690Q36169439-36EAA644-5384-4F4B-9CB7-47D6DC89955FQ36180739-6D1D2AAB-4535-4869-A1AD-2159C9E4C9D2Q36210416-20AFF5D6-E610-4EF9-979A-E24F2E14DAF2Q36953248-FE85F766-7BB9-4B25-8D13-9F518F523822Q37002169-2D74BC76-EE30-42B1-AFB6-1149B5BCB9C8Q37286643-F42C6E69-14F6-4E73-A564-C60443EF8568Q37294189-1ABF7779-6A21-4DFF-9237-34AA76E02E80Q37696036-6007273A-DB48-455A-A2FA-95E4AADF6FBBQ38079586-08557F9B-06B2-40A9-85ED-5080D4C0C0EAQ38855132-A702381E-BD8F-4576-A226-F738D7A6ABA0Q41644080-38DC07A1-DA44-4DB2-BFA5-F2D652500F4EQ47121817-4F96F09E-527A-461F-AF26-E510C947919BQ50935834-A31DC7B5-E067-44A8-8607-1262AD11F668Q51334586-D0E10837-98FD-46D3-AC9A-A9598EB3A098Q51365039-37E54D87-4720-4071-992B-5C064020B0DEQ52714523-5AA67AEE-179A-4F26-B62E-C1D391B5444C
P2860
Cystatin m: a novel candidate tumor suppressor gene for breast cancer.
description
2004 nî lūn-bûn
@nan
2004 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Cystatin m: a novel candidate tumor suppressor gene for breast cancer.
@ast
Cystatin m: a novel candidate tumor suppressor gene for breast cancer.
@en
type
label
Cystatin m: a novel candidate tumor suppressor gene for breast cancer.
@ast
Cystatin m: a novel candidate tumor suppressor gene for breast cancer.
@en
prefLabel
Cystatin m: a novel candidate tumor suppressor gene for breast cancer.
@ast
Cystatin m: a novel candidate tumor suppressor gene for breast cancer.
@en
P2093
P1433
P1476
Cystatin m: a novel candidate tumor suppressor gene for breast cancer
@en
P2093
Benjamin D L Li
Bonnie F Sloane
Carol Meschonat
Daniel Keppler
Fleurette Abreo
Fred R Miller
Ravi Shridhar
P304
P356
10.1158/0008-5472.CAN-04-0819
P407
P50
P577
2004-10-01T00:00:00Z